Expression of metallothionein-III and cell death in differentiated catecholaminergic neuronal cells

Neurological Research

Volumn 26, Issue 6, 2004, Pages 671-676

  Higashi, Youichirou ^a   Asanuma, Masato ^a   Miyazaki, Ikuko ^a   Ogawa, Norio ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Differentiation; Growth inhibitory factor; Metallothionein III

Indexed keywords

BRAIN EXTRACT; BUCLADESINE; CATECHOLAMINE; GROWTH INHIBITOR; MESSENGER RNA; METALLOTHIONEIN III; NEUROMODULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE NERVE CELL; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; FOREBRAIN; GROWTH REGULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; CATECHOLAMINES; CELL DEATH; CELL DIFFERENTIATION; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MALE; METALLOTHIONEIN; MICE; MICE, INBRED ICR; NERVE TISSUE PROTEINS; NEURONS;

EID: 12544250155     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164104225015895     Document Type: Article

References (16)

1. Uchida Y, Takio K, Titani K, et al. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 1991; 7: 337-347
2. Tsuji S, Kobayashi H, Uchida Y, et al. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. EMBO J 1992; 11: 4843-4850
3. Erickson JC, Sewell AK, Jensen LT, et al. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res 1994; 649: 297-304
4. Hozumi I, Inuzuka T, Ishiguro H, et al. Immunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds - an immunocytochemical study using confocal laser scan microscope. Brain Res 1996; 741: 197-204
5. Aoki Sogawa C, Asanuma M, Sogawa N, et al. Localization, regulation, and function of metallothionein-III/growth inhibitory factor in the brain. Acta Med Okayama 2001; 55: 1-9
6. Erickson JC, Hollopeter C, Thomas SA, et al. Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J Neurosci 1997; 17: 1271-1281
7. Yeiser EC, Fitch CA, Horning MS, et al. Regulation of metallothionein-3 mRNA by thyroid hormone in developing rat brain and primary cultures of rat astrocytes and neurons. Dev Brain Res 1999; 115: 195-200
8. Bundey RA, Jones PC, Kendall DA. An investigation of noradrenaline uptake and release by the CATH, a cell line. J Neurochem 2000; 74: 799-806
9. Aoki Sogawa C, Miyazaki I, Sogawa N, et al. Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2 g). Brain Res 2000; 853: 310-316
10. Miyazaki I, Aoki Sogawa C, Asanuma M, et al. Expression of metallothionein-III mRNA and its regulation by levodopa in the basal ganglia of hemi-parkinsonian rats. Neurosci Lett 2000; 293: 65-68
11. Higashi Y, Asanuma M, Miyazaki I, et al. Inhibition of tyrosinase reduces cell viability in catecholaminergic neuronal cells. J Neurochem 2000; 75: 1771-1774
12. Asanuma M, Hayashi T, Ordonez SV, et al. Direct interactions of methamphetamine with the nucleus. Mol Brain Res 2000; 80: 237-243
13. Arai Y, Uchida Y, Takashima S. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome. Pediatr Neurol 1997; 17: 134-138
14. Gorgels TG, Oestreicher AB, de KE, et al. Immunocytochemical distribution of the protein kinase C substrate B-50 (GAP43) in developing rat pyramidal tract. Neurosci Lett 1987; 83: 59-64
15. van Hooff CO, Holthuis JC, Oestreicher AB, et al. Nerve growth factor-induced changes in the intracellular localization of the protein kinase C substrate B-50 in pheochromocytoma PC12 cells. J Cell Biol 1989; 108: 1115-1125
16. Mani S, Schaefer J, Meiri KF. Targeted disruption of GAP-43 in P19 embryonal carcinoma cells inhibits neuronal differentiation. As well as acquisition of the morphological phenotype. Brain Res 2000; 853: 384-395